{
    "ticker": "SLGL",
    "name": "Sol-Gel Technologies Ltd.",
    "description": "Sol-Gel Technologies Ltd. is a clinical-stage pharmaceutical company focused on developing and commercializing innovative dermatological products. Founded in 2010, Sol-Gel is dedicated to advancing treatments for skin diseases, leveraging its proprietary technology platform. The company has developed a range of product candidates, including its lead product, which aims to treat acne vulgaris with a unique formulation that combines two well-known active ingredients. Sol-Gel's mission is to provide patients with effective, safe, and convenient treatment options while addressing unmet medical needs in dermatology. The company's research and development efforts are supported by a strong intellectual property portfolio, which allows Sol-Gel to protect its innovations and market its products effectively. In addition to acne treatments, Sol-Gel is also exploring therapies for psoriasis and other dermatological conditions. With a commitment to scientific excellence and patient care, Sol-Gel Technologies is poised to make significant contributions to the field of dermatology.",
    "industry": [
        "Pharmaceuticals",
        "Biotechnology"
    ],
    "headquarters": "Rehovot, Israel",
    "founded": "2010",
    "website": "https://www.sol-gel.com",
    "ceo": "Alon A. C. Koren",
    "social_media": {
        "twitter": "https://twitter.com/SolGelTech",
        "linkedin": "https://www.linkedin.com/company/sol-gel-technologies/"
    },
    "investor_relations": "https://investors.sol-gel.com",
    "key_executives": [
        {
            "name": "Alon A. C. Koren",
            "position": "CEO"
        },
        {
            "name": "Ron Cohen",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Dermatological Products",
            "products": [
                "Acne Treatment",
                "Psoriasis Treatment"
            ]
        }
    ],
    "seo": {
        "meta_title": "Sol-Gel Technologies Ltd. | Innovative Dermatological Solutions",
        "meta_description": "Explore Sol-Gel Technologies Ltd., a clinical-stage pharmaceutical company dedicated to developing innovative treatments for dermatological conditions like acne and psoriasis.",
        "keywords": [
            "Sol-Gel",
            "Dermatology",
            "Pharmaceuticals",
            "Acne Treatment",
            "Psoriasis Treatment"
        ]
    },
    "faq": [
        {
            "question": "What is Sol-Gel Technologies known for?",
            "answer": "Sol-Gel Technologies is known for developing innovative dermatological products, particularly for acne and psoriasis."
        },
        {
            "question": "Who is the CEO of Sol-Gel Technologies?",
            "answer": "Alon A. C. Koren is the CEO of Sol-Gel Technologies Ltd."
        },
        {
            "question": "Where is Sol-Gel headquartered?",
            "answer": "Sol-Gel is headquartered in Rehovot, Israel."
        },
        {
            "question": "What are the main products of Sol-Gel?",
            "answer": "The main products include treatments for acne vulgaris and psoriasis."
        },
        {
            "question": "When was Sol-Gel founded?",
            "answer": "Sol-Gel was founded in 2010."
        }
    ],
    "competitors": [
        "VRNA",
        "PFE",
        "JNJ",
        "ABBV"
    ],
    "related_stocks": [
        "AMGN",
        "REGN",
        "GILD",
        "BMY"
    ]
}